Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans

We used data obtained by Caris Life Sciences, to evaluate the benefits of tailoring treatments for a breast carcinoma cohort by using tumor molecular profiles to inform decisions. Data for 92 breast cancer patients from the commercial Caris Molecular Intelligence database was retrospectively divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Philip, Alifrangis, Costi, Cereser, Biancastella, Chandrasinghe, Pramodh, Del Bel Belluz, Lisa, Moderau, Nina, Poyia, Fotini, Schwartzberg, Lee S., Tabassum, Neha, Wen, Jinrui, Krell, Jonathan, Stebbing, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915140/
https://www.ncbi.nlm.nih.gov/pubmed/29707132
http://dx.doi.org/10.18632/oncotarget.24564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915140/
https://www.ncbi.nlm.nih.gov/pubmed/29707132
http://dx.doi.org/10.18632/oncotarget.24564

Ejemplares similares